Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relevance of biomarkers in disease progression in multiple sclerosis.
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.
Longitudinal extensive transverse myelitis and Zika virus: A diagnostic challenge in a hospital in Colombia.
Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus.
Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment.
Epigenetic control of oligodendrocyte development: adding new players to old keepers.
The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression.
The Role of Obstructive Sleep Apnea in Cognitive Dysfunction in Multiple Sclerosis.
Adult-onset Krabbe disease presenting as acute hemiparesis and progressive demyelination detected by diffusion-weighted imaging.
High-Resolution Expression Profiling of Peripheral Blood CD8(+) Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.
Increased THEMIS First Exon Usage in CD4+ T-Cells Is Associated with a Genotype that Is Protective against Multiple Sclerosis.
Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.
Reduced fecal GABA levels in multiple sclerosis patients.
Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.
FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs
Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study.
Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism.
Neurotrophins' Modulation by Olive Polyphenols.
T-bet promotes the accumulation of encephalitogenic Th17 cells in the CNS.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).
Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Conclusions: Calls to action for improving the life of MS patients and their families.
"Gait responder" to fampridine, a too restrictive concept?
Pages
« first
‹ previous
…
752
753
754
755
756
757
758
759
760
…
next ›
last »